Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berthold Seitz

Showing results (641-650 of 671) with videos related to

Pageof 68
Sort By:
Journal of the American College of Cardiology|May 10, 2006
A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cellsRüdiger Blindt, Felix Vogt, Irina Astafieva, et al.
Ophthalmology and Therapy|March 26, 2025
Comprehensive Analysis of Congenital Aniridia and Differential Diagnoses: Genetic Insights and Clinical ManifestationsJonathan Hall, Marta Corton, Fabian Norbert Fries, et al.
Ophthalmology|August 1, 2009
GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trialClaus Cursiefen, Felix Bock, Folkert K Horn, et al.
The British Journal of Ophthalmology|June 30, 2011
Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtableClaus Cursiefen, Joseph Colin, Reza Dana, et al.
European Journal of Ophthalmology|March 20, 2019
Three-year results from the Retro-IDEAL study: Real-world data from diabetic macular edema (DME) patients treated with ILUVIEN<sup>®</sup> (0.19 mg fluocinolone acetonide implant)Albert J Augustin, Silvia Bopp, Martin Fechner, et al.
European Journal of Ophthalmology|May 5, 2021
The impact of vitrectomy on outcomes achieved with 0.19 mg fluocinolone acetonide implant in patients with diabetic macular edemaAlbert J Augustin, Silvia Bopp, Martin Fechner, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 29, 2025
Comparing Rotational Stability Over Time Between Four Monofocal Toric Intraocular LensesPeter Hoffmann, Richard Potvin, Robert D Anello, et al.
Acta Ophthalmologica|September 30, 2022
DMEK outcome after one year - Results from a large multicenter study in GermanyKristina Spaniol, Martin Hellmich, Klara Borgardts, et al.
Trials|March 6, 2024
UV light-mediated corneal crosslinking as (lymph)angioregressive pretreatment to promote graft survival after subsequent high-risk corneal transplantation (CrossCornealVision): protocol for a multicenter, randomized controlled trialJohanna Wiedemann, Deniz Hos, Endrik Limburg, et al.
Genomics, Proteomics & Bioinformatics|June 9, 2022
Systematic Cross-biospecimen Evaluation of DNA Extraction Kits for Long- and Short-read Multi-metagenomic Sequencing StudiesJacqueline Rehner, Georges Pierre Schmartz, Laura Groeger, et al.
Pageof 68

Showing results (641-650 of 671) with videos related to

Sort By:
Pageof 68
Journal of the American College of Cardiology|May 10, 2006
A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cellsRüdiger Blindt, Felix Vogt, Irina Astafieva, et al.
Ophthalmology and Therapy|March 26, 2025
Comprehensive Analysis of Congenital Aniridia and Differential Diagnoses: Genetic Insights and Clinical ManifestationsJonathan Hall, Marta Corton, Fabian Norbert Fries, et al.
Ophthalmology|August 1, 2009
GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trialClaus Cursiefen, Felix Bock, Folkert K Horn, et al.
The British Journal of Ophthalmology|June 30, 2011
Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtableClaus Cursiefen, Joseph Colin, Reza Dana, et al.
European Journal of Ophthalmology|March 20, 2019
Three-year results from the Retro-IDEAL study: Real-world data from diabetic macular edema (DME) patients treated with ILUVIEN<sup>®</sup> (0.19 mg fluocinolone acetonide implant)Albert J Augustin, Silvia Bopp, Martin Fechner, et al.
European Journal of Ophthalmology|May 5, 2021
The impact of vitrectomy on outcomes achieved with 0.19 mg fluocinolone acetonide implant in patients with diabetic macular edemaAlbert J Augustin, Silvia Bopp, Martin Fechner, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 29, 2025
Comparing Rotational Stability Over Time Between Four Monofocal Toric Intraocular LensesPeter Hoffmann, Richard Potvin, Robert D Anello, et al.
Acta Ophthalmologica|September 30, 2022
DMEK outcome after one year - Results from a large multicenter study in GermanyKristina Spaniol, Martin Hellmich, Klara Borgardts, et al.
Trials|March 6, 2024
UV light-mediated corneal crosslinking as (lymph)angioregressive pretreatment to promote graft survival after subsequent high-risk corneal transplantation (CrossCornealVision): protocol for a multicenter, randomized controlled trialJohanna Wiedemann, Deniz Hos, Endrik Limburg, et al.
Genomics, Proteomics & Bioinformatics|June 9, 2022
Systematic Cross-biospecimen Evaluation of DNA Extraction Kits for Long- and Short-read Multi-metagenomic Sequencing StudiesJacqueline Rehner, Georges Pierre Schmartz, Laura Groeger, et al.
Pageof 68